ArticleClinical and experimental nephrology2022

Correction to: Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study.

Shuichi Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.